Zim Laboratories Ltd.
NSE: ZIMLAB | BSE: 541400
₹122.69
₹-2.77
(-2.21%)
As on 31-Aug-2026IST
Market cap
₹663 Cr
Revenue (TTM)
₹397 Cr
P/E Ratio
179.5
P/B Ratio
2.3
Div. Yield
0 %
Quality Score
1/10
Growth Score
4/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
2.1 %
-
ROCE
5.5 %
-
Industry P/E
33.94
-
EV/EBITDA
19
-
Debt to Equity
0.4
-
Book Value
₹54.2
-
EPS
₹0.8
-
Face value
10
-
Shares outstanding
53,658,488
10 Years Aggregate
CFO
₹351.79 Cr
EBITDA
₹378.71 Cr
Net Profit
₹137.89 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zim Laboratories
| 70.0 | 10.0 | 19.9 | 62.7 | -2.3 | -- | -- |
|
BSE Healthcare
| 18.7 | 1.7 | 10.2 | 18.2 | 22.8 | 14.5 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Zim Laboratories
| -33.5 | -9.0 | 18.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zim Laboratories
|
122.7 | 663.5 | 396.8 | 3.7 | 1.9 | 1.4 | 179.5 | 2.3 |
| 6,951.5 | 17,426.9 | 2,432.1 | 169.6 | 8.7 | 20.8 | 102.7 | 19.3 | |
| 2,517.4 | 19,134.0 | 2,287.3 | 678.1 | 31.4 | 19.7 | 28.8 | 5.1 | |
| 2,050.3 | 12,525.9 | 1,479.1 | 198.6 | 18.6 | 30.3 | 62.9 | 15.5 | |
| 1,297.2 | 17,987.4 | 3,229.7 | 666.9 | 26.6 | 18.8 | 27.9 | 4.4 | |
| 4,684.4 | 21,441.1 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.2 | 4.9 | |
| 5,768.0 | 9,562.1 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.8 | 15.5 | |
| 3,124.0 | 7,200.6 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.2 | 8.7 | |
| 949.3 | 18,581.3 | 1,682.5 | 273.5 | 21.0 | 11.1 | 62.5 | 6.9 | |
| 1,025.0 | 9,444.0 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.4 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Zim Laboratories
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in... the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was founded in 1984 and is based in Nagpur, India. Read more
-
Incorporated
1984
-
Chairman
Anwar Siraj Daud
-
Managing Director
Anwar Siraj Daud
-
Group
MNC
-
Headquarters
Nagpur, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zim Laboratories
What is the current share price of Zim Laboratories Ltd Today?
The share price of Zim Laboratories Ltd is ₹122.69 (NSE) and ₹123.65 (BSE) as of 31-Aug-2026 IST. Zim Laboratories Ltd has given a return of -2.32% in the last 3 years.
What is the current PB & PE ratio of Zim Laboratories Ltd?
The P/E ratio of Zim Laboratories Ltd is 179.51 times as on 31-Aug-2026, a 429 premium to its peers’ median range of 33.94 times.
The P/B ratio of Zim Laboratories Ltd is 2.28 times as on 31-Aug-2026, a 55 discount to its peers’ median range of 5.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
54.87 |
1.09 |
2025 |
32.12 |
1.56 |
2024 |
26.98 |
1.95 |
2023 |
14.44 |
1.76 |
2022 |
5.95 |
1.48 |
What is the 52 Week High and Low of Zim Laboratories Ltd?
The 52-week high and low of Zim Laboratories Ltd are Rs 133.90 and Rs 59.31 as of 01-Sep-2026.
What is the market cap of Zim Laboratories Ltd?
Zim Laboratories Ltd has a market capitalisation of ₹ 663 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Zim Laboratories Ltd?
Before investing in Zim Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.